I Naruse Selected Research

Drug Therapy (Chemotherapy)

9/2000	Weekly CODE chemotherapy with recombinant human granulocyte colony-stimulating factor for relapsed or refractory small cell lung cancer.
4/2000	A phase II study of combined chemoradiotherapy for limited disease-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

I Naruse Research Topics

Disease

2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2000 - 04/2000
1	Lung Neoplasms (Lung Cancer) 11/2000
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 07/2000
1	Bacterial Pneumonia 01/2000
1	Infections 01/2000

Drug/Important Bio-Agent (IBA)

2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2000 - 04/2000
2	Cisplatin (Platino)FDA LinkGeneric 09/2000 - 04/2000
2	Etoposide (VP 16)FDA LinkGeneric 09/2000 - 04/2000
1	Complementary DNA (cDNA)IBA 11/2000
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2000
1	Vincristine (Oncovin)FDA LinkGeneric 09/2000
1	CREB-Binding ProteinIBA 07/2000
1	Interleukin-12 (IL 12)IBA 01/2000
1	Interleukin-10 (Interleukin 10)IBA 01/2000

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 09/2000 - 04/2000
1	Therapeutics 11/2000
1	Chemoradiotherapy 04/2000
1	Radiotherapy 04/2000